One in eight adults has taken a GLP-1 agonist, a drug used to treat obesity and diabetes, such as Ozempic, Munjaro, or Zepbound, according to a poll by the health policy nonprofit KFF. is answering. Of those surveyed, 12% said they had used GLP-1 agonists, and 6% said they were currently using them. The majority of them (62%) said they use drugs to treat chronic conditions such as diabetes…
|